- Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study2021 | Second Faculty of Medicine
- Repurposing anthelmintic agents to eradicate resistant leukemia2020 | Second Faculty of Medicine
- Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease2022 | Second Faculty of Medicine
- Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions2022 | Second Faculty of Medicine
- Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial2022 | Second Faculty of Medicine
- Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT2020 | Publication without faculty affiliation